Bngo stock price rose 1

BNGO stock price rose 1.6% amid steady buy-side accumulation in morning trading. Market participants highlight upcoming research conference as a likely catalyst. A link to register for this meeting is listed on the AMA Association website. Looking ahead, we remain on track to meet our goal of installing 381 to 401 OGM systems by the end of 2024, which reflects some anticipated Saphyr to Stratys upgrades. We expect Q2 revenue guidance to be in the range of $7.8 million to $8.2 million, and we are maintaining our full-year 2024 revenue guidance of $37 million to $41 million. Keep in mind that both of these ranges take into account the financial impact of discontinuing certain clinical services products as part of our cost-reduction initiatives. FSMAX - Fidelity Extended Market Index Fund holds 489K shares representing 17.89% ownership of the company. In its prior filing, the firm reported owning 375K shares , representing an increase of 23.32%. The firm decreased its portfolio allocation in BNGO by 36.03% over the last quarter. Chart analysts note key resistance near $0.68, with strong support forming at $0.